EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Liquid biopsy in cutaneous oncology: Current practice and future directions

Sabah Choudhury, Adewunmi O Adelaja, Haley Ann Neff, David M Miller, Emily S Ruiz, Ryan J Sullivan, Rhoda M Alani

Journal of the American Academy of Dermatology · 2026-07

DOI: 10.1016/j.jaad.2026.07.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Sabah Choudhury und 6 weiteren Autor:innen. Beteiligte Einrichtung: Boston University School of Medicine, Boston, Massachusetts. Die Arbeit nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past decade, the development and implementation of novel circulating tumor "liquid biopsies" in clinical practice has revolutionized cancer care. These tools provide sensitive and specific analysis of tumor status which enable non-invasive alternatives to tissue biopsy for real-time tumor monitoring, guided targeted therapy, predicted treatment response, and assessing therapeutic resistance and residual disease. The FDA has already approved several assays to detect genetic alterations in plasma cell-free DNA for use as companion diagnostics matched to specific molecularly targeted therapies for cancer, setting the stage for future use in early relapse detection and additional applications which are expected to be incorporated into standard-of-care practices for aggressive cutaneous malignancies. It will therefore be important for the dermatology community to have a working knowledge of liquid biopsy techniques and their relevance to the management of cutaneous malignancies. This review highlights state-of-the-art liquid biopsy tools currently in practice with an emphasis on the development and implementation of circulating biomarkers in skin cancers. It is anticipated that liquid biopsy tools will soon become integrated into evolving standards-of-care for improved management of patients with aggressive cutaneous malignancies.

Schlagwörter

Stichwörter der Autor:innen

Merkel cell carcinomabasal cell carcinomacell-free DNAcirculating biomarkerscutaneous T-cell lymphomacutaneous oncologycutaneous squamous cell carcinomaliquid biopsymelanoma

Autor:innen und Institutionen

  • Boston University School of Medicine, Boston, Massachusetts.
  • Harvard Combined Dermatology Residency Training Program, Boston, Massachusetts.
  • Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Harvard Medical School, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Massachusetts General Brigham Cancer Institute, Boston, Massachusetts.
  • Harvard Medical School, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Georgetown University School of Medicine, Washington, District of Co…

Zitieren

APA

Choudhury, S., Adelaja, A. O., Neff, H. A., Miller, D. M., Ruiz, E. S., Sullivan, R. J., & Alani, R. M. (2026). Liquid biopsy in cutaneous oncology: Current practice and future directions. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.07.005

Vancouver

Choudhury S, Adelaja AO, Neff HA, Miller DM, Ruiz ES, Sullivan RJ, et al. Liquid biopsy in cutaneous oncology: Current practice and future directions. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.07.005

BibTeX
@article{Choudhury2026,
  author = {Choudhury, Sabah and Adelaja, Adewunmi O and Neff, Haley Ann and Miller, David M and Ruiz, Emily S and Sullivan, Ryan J and Alani, Rhoda M},
  title = {Liquid biopsy in cutaneous oncology: Current practice and future directions},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2026.07.005}
}
Kostenlos starten →